» Authors » Peter T Donnan

Peter T Donnan

Explore the profile of Peter T Donnan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 148
Citations 3316
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
De Souza N, Guthrie B, Grant S, Lorencatto F, Dickson J, Herbec A, et al.
Age Ageing . 2025 Jan; 54(1. PMID: 39780740
Background: There is wide variation in antibiotic prescribing across care-homes for older people, with implications for resident outcomes and antimicrobial resistance. Objective: To quantify variation in antibiotic prescribing and associations...
2.
Shrestha A, Bashir T, Achison M, Adamson S, Akpan A, Aspray T, et al.
PLoS One . 2024 Aug; 19(8):e0307268. PMID: 39093910
Introduction: Understanding genetic contributors to sarcopenia (age-related loss of muscle strength and mass) is key to finding effective therapies. Variants of the bradykinin receptor 2 (BDKRB2) have been linked to...
3.
Miller M, McCann L, Lewis L, Miaskowski C, Ream E, Darley A, et al.
J Med Internet Res . 2024 Jun; 26:e49309. PMID: 38901021
Background: Interest in the application of predictive risk models (PRMs) in health care to identify people most likely to experience disease and treatment-related complications is increasing. In cancer care, these...
4.
Ciaccio L, Donnan P, Parcell B, Marwick C
BMJ Open . 2024 Apr; 14(4):e081930. PMID: 38643000
Objectives: This study aims to examine community antibiotic prescribing across a complete geographical area for people with a positive COVID-19 test across three pandemic waves, and to examine health and...
5.
Bashir T, Achison M, Adamson S, Akpan A, Aspray T, Avenell A, et al.
PLoS One . 2023 Nov; 18(11):e0294330. PMID: 37963137
Background: Ageing is associated with changes in body composition including an overall reduction in muscle mass and a proportionate increase in fat mass. Sarcopenia is characterised by losses in both...
6.
Rossios C, Bashir T, Achison M, Adamson S, Akpan A, Aspray T, et al.
PLoS One . 2023 Oct; 18(10):e0292402. PMID: 37862321
Background: Angiotensin II (AII), has been suggested to promote muscle loss. Reducing AII synthesis, by inhibiting angiotensin converting enzyme (ACE) activity has been proposed as a method to inhibit muscle...
7.
Wei C, Szewczyk-Bieda M, Bates A, Donnan P, Rauchhaus P, Gandy S, et al.
Radiology . 2023 Jul; 308(1):e221428. PMID: 37489992
Background The optimal diagnostic pathway for prostate cancer (PCa) is evolving, requiring further evaluation in a randomized controlled trial. Purpose To assess the diagnostic accuracy of prebiopsy multiparametric MRI in...
8.
Livingstone S, Morales D, Fleuriot J, Donnan P, Guthrie B
BMC Cardiovasc Disord . 2023 Apr; 23(1):194. PMID: 37061672
Background: Prediction of lifetime cardiovascular disease (CVD) risk is recommended in many clinical guidelines, but lifetime risk models are rarely externally validated. The aim of this study was to externally...
9.
Mills S, Brown-Kerr A, Buchanan D, Donnan P, Smith B
Br J Gen Pract . 2023 Jan; 73(727):e124-e132. PMID: 36702608
Background: People with advanced cancer frequently use the GP out-of-hours (GPOOH) service. Considerable amounts of routine GPOOH data are uncoded. Therefore, these data are omitted from existing healthcare datasets. Aim:...
10.
Livingstone S, Guthrie B, McMinn M, Eke C, Donnan P, Morales D
Lancet Healthy Longev . 2023 Jan; 4(1):e43-e53. PMID: 36610448
Background: UK guidelines recommend the QFracture tool to predict the risk of major osteoporotic fracture and hip fracture, but QFracture calibration is poor, partly because it does not account for...